These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26390739)

  • 1. Shake Up in the Neostig- mine Methylsulfate Cholin- esterase Inhibitor Market for Neuromuscular Block Reversal.
    Welliver M
    AANA J; 2015 Aug; 83(4):240-2. PubMed ID: 26390739
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular block in children.
    Fawcett WJ
    Br J Anaesth; 1997 May; 78(5):627. PubMed ID: 9175986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of neuromuscular blocking drugs and sugammadex expenses, one year after its introduction into routine clinical practice].
    Raft J; Chenot ED; Longrois D; Meistelman C
    Ann Fr Anesth Reanim; 2011 Oct; 30(10):758-9. PubMed ID: 21820269
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed reversal of a potentiated rocuronium neuromuscular block.
    Dubois PE
    Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
    [No Abstract]   [Full Text] [Related]  

  • 5. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
    Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
    [No Abstract]   [Full Text] [Related]  

  • 9. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
    Lien CA
    Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
    [No Abstract]   [Full Text] [Related]  

  • 10. Neostigmine product for NMBA reversal approved by FDA.
    Thompson CA
    Am J Health Syst Pharm; 2013 Jul; 70(14):1184. PubMed ID: 23820450
    [No Abstract]   [Full Text] [Related]  

  • 11. Neostigmine Hyperinflation.
    Hamel AG; Recker MW
    J Pharm Pract; 2018 Aug; 31(4):395-398. PubMed ID: 29528806
    [No Abstract]   [Full Text] [Related]  

  • 12. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of mivacurium-induced neuromuscular block by neostigmine.
    Baraka A
    Middle East J Anaesthesiol; 2001 Feb; 16(1):3-5. PubMed ID: 11281046
    [No Abstract]   [Full Text] [Related]  

  • 16. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.
    Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
    Martin-Flores M; Boesch J; Campoy L; Gleed RD
    J Am Anim Hosp Assoc; 2011; 47(4):294-8. PubMed ID: 21673340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of reversal of myoneural blockade on cerebrospinal fluid pressure following cerebral aneurysm surgery.
    Fawcett WJ; Chung RA; Fairley CJ; Hollway TE
    Eur J Anaesthesiol; 1995 Nov; 12(6):591-5. PubMed ID: 8665882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.